FDA Inspection 629551 — Akorn, Inc.

Akorn, Inc. — FEI 3003102962

The FDA completed an inspection of Akorn, Inc. on Nov 10, 2009 in Gurnee, IL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Nov 10, 2009
Fiscal Year
2010
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Gurnee, IL (United States)

Additional details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
241921 CFR 211.198(a)Complaint Handling Procedure
261921 CFR 211.198(b)(2)Complaint Investigation/Follow-Up Findings

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.